US 10105434
Immune enhancing recombinant dengue protein
granted A61KA61K2039/5252A61K2039/53
Quick answer
US patent 10105434 (Immune enhancing recombinant dengue protein) held by United States of America as represented by the Secretary of the Air Force expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Air Force
- Grant date
- Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/5252, A61K2039/53, A61K2039/545, A61K2039/55516